Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Chemotherapy for ovarian mucinous cystadenocarcinoma during pregnancy: A case report
1Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Republic of China
2National Yang-Ming Medical University, Taipei, Taiwan, Republic of China
*Corresponding Author(s): C.-N. Fang E-mail:
There is limited experience in the treatment of epithelial ovarian malignancy with chemotherapy during pregnancy. We present the case of a 36-year-old women with ovarian mucinous cystadenocarcinoma during pregnancy, on whom exploratory laparotomy was performed at the gestational age of 16 weeks. Afterwards chemotherapy with cyclophosphamide (500 mg/m2) and cisplatin (50 mg/m2) was administered beginning at the second trimester of pregnancy due to surgical Stage Ic. Although preterm labor and a prematurely ruptured membrane occurred at the gestational age of 29 weeks before the fourth course of chemotherapy, there was still a satisfactory outcome for mother and fetus after an emergency cesarean section due to breech presentation at the gestational age of 30 weeks.
Ovarian malignancy; Chemotherapy; Pregnancy
H.-P. Huang,C.-N. Fang,Y.-Y. Kan. Chemotherapy for ovarian mucinous cystadenocarcinoma during pregnancy: A case report. European Journal of Gynaecological Oncology. 2004. 25(5);635-636.
[1] Hoffman M., Cavanagh D., Walter T., lonata E., Ruffolo E.: "Adenocarcinoma of the endometrium with pregnancy". Gynecol Oneal., 1989, 32, 82
[2] Doll D.C., Ringenberg S., Yarbo J.W.: "Antineoplastic agents and pregnancy". Semin. Oncol., 1989, 16, 337
[3] Ebert U., Loffler H., Kirch W.: "Cytotoxic therapy and pregnancy". Pharmacol. Ther., 1997, 74 (2), 207.
[4] Raffles A., Williams J., Costeloe K., Clark P.: "Transplacental effects of maternal cancer chemotherapy: Case report". Br..I Obstet. Gynaecol., 1989, 96, 1099.
[5] Kai S., Kohmura H., Hiraiwa E. et al.: "Reproductive and developmental toxicity studies of paclitaxel. IL Intravenous administration to rats during the fetal organogenesis". J. Toxicol. Sci., 1994, 19S, 69.
[6] Sood AK., Shahin M.S., Sorosky J.I.: "Paclitaxel and platmum chemotherapy for ovarian carcinoma during pregnancy". Gynecol Oncology, 2001, 83 (3), 599.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Top